1. Home
  2. SLP vs TKNO Comparison

SLP vs TKNO Comparison

Compare SLP & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simulations Plus Inc.

SLP

Simulations Plus Inc.

HOLD

Current Price

$18.37

Market Cap

367.9M

Sector

Technology

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$5.03

Market Cap

308.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLP
TKNO
Founded
1996
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.9M
308.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SLP
TKNO
Price
$18.37
$5.03
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$24.00
N/A
AVG Volume (30 Days)
577.8K
137.9K
Earning Date
04-09-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
0.43
N/A
Revenue
$59,577,000.00
$40,520,000.00
Revenue This Year
$3.80
$8.27
Revenue Next Year
$5.90
$13.13
P/E Ratio
$42.63
N/A
Revenue Growth
10.52
7.35
52 Week Low
$11.09
$1.91
52 Week High
$21.01
$6.68

Technical Indicators

Market Signals
Indicator
SLP
TKNO
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SLP
TKNO

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Share on Social Networks: